February 12, 2020
SymBio Pharmaceuticals Limited
Fuminori Yoshida
Representative Director,President and Chief Executive Officer
Completion, Monthly Exercise Status and Large Volume Exercise of the 47th Stock Acquisition Rights(with Exercise Price Revision Clauses) Issued by way of Third Party Allotment
TOKYO, Japan, February 12, 2020—SymBio Pharmaceuticals Limited (JASDAQ: 4582) announces the monthly
exercise status and the large volume exercise of the 46th Stock Acquisition Rights issued during the period from February 3,2020 to February 12, 2020, and that the exercise of all 47th stock acquisition rights issued and allotted to EVO FUND on
April 25, 2018, are completed as of today.
I. The Large Volume Exercise
Name of the stock acquisition(1)

SymBio Pharmaceuticals Limited 47th Stock Acquisition Rightsrights
Number of issued shares from the(2)beginning of the month
Number of stock acquisition rights
being exercised from the(3)575,000 Shares
2,300,000 Units（Ratio to the total number of stock acquisition rights issued 15,000,000

beginning of the month and theunits ：15.33％）

ratio to the entire issue
Number of unexercised stock(4)

acquisition rights as of the2,300,000 Unitsbeginning of the month
Number of remaining(5)

unexcercised stock acquisition

0 Unitsrights as of today(6) Exercise status from the previous disclosure
Number of delivered shares
Exercise Date

New Shares (Shares)

Treasury Shares

Number of stock
Exercise Price (¥)

Transferred (Shares)

acquisition rights
being excercised(Units)

February ３ (Mon)

--

560

-

February ４ (Tue)

-

-

560

-

February ５ (Wed)

--

560

-

February ６ (Thu)

--

552

-

February ７ (Fri)

--

552

-

February 10 (Mon)350,000-

552

1,400,000

February 12 (Wed)225,000-552

900,000※Number of issued shares at the end of the previous month：27,537,681 shares〔of which 20,343 shares are treasuryshares〕

1II. Monthly Exercise Status
Name of the stock acquisition(1)

SymBio Pharmaceuticals Limited 47th Stock Acquisition Rights

rightsNumber of issued shares from the(2)575,000 Shares

beginning of the month
Number of stock acquisition rights
being exercised from the(3)2,300,000 Units(Ratio to the total number of stock acquisition rights issued 15,000,000

beginning of the month and theunits ：15.33%）

ratio to the entire issue
Number of unexercised stock(4)

acquisition rights as of the2,300,000 Units

beginning of the month
Number of remaining(5)

unexcercised stock acquisition

0 Unitsrights as of today(6) Exercise status from the beginning of the month
Number of delivered shares
Exercise Date

New Shares (Shares)

Treasury Shares

Number of stock
Exercise Price (¥)

Transferred (Shares)

acquisition rights
being excercised(Units)

February 3 (Mon)

--

560

-

February 4 (Tue)

--

560

-

February 5 (Wed)

--

560

-

February 6 (Thu)

--

552

-

February 7 (Fri)

--

552

-

February 10 (Mon)350,000-

552

1,400,000

February 12 (Wed)225,000-552

900,000※Number of issued shares at the end of the previous month：27,537,681 shares〔of which 20,343 shares are treasuryshares〕(7) Status concerning restriction on exercise (Status concerning compliance with exercise restrictions under Article 434 of
the Listing Regulations)①

Total number of shares to be②

Number of listed shares at thedelivered upon the exercise oftime of the payment for the

all series of stock acquisition

issuance③

Exercise ratio on exercise
limit(①/②)

rights575,000 Shares

14,460,181Shares2

3.98％